As mitochondrial function declines, it leads to cellular alterations observed in AD, such as amyloid-β (Aβ) production, tau phosphorylation, synaptic degeneration, and oxidative stress (Swerdlow, 2011, 2012). The gene discussed is MAPT; the disease is Alzheimer disease.